UniProt ID | RED_HUMAN | |
---|---|---|
UniProt AC | Q13123 | |
Protein Name | Protein Red {ECO:0000303|PubMed:10216252} | |
Gene Name | IK | |
Organism | Homo sapiens (Human). | |
Sequence Length | 557 | |
Subcellular Localization | Nucleus . Nucleus, nucleoplasm . Chromosome . Cytoplasm, cytoskeleton, spindle pole . Predominantly present throughout the nucleoplasm during prometaphase, metaphase and anaphase. Is also detected in nuclear foci that are not identical with Cajal bod | |
Protein Description | Involved in pre-mRNA splicing as a component of the spliceosome. [PubMed: 28781166 Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable Required for normal mitotic cell cycle progression] | |
Protein Sequence | MPERDSEPFSNPLAPDGHDVDDPHSFHQSKLTNEDFRKLLMTPRAAPTSAPPSKSRHHEMPREYNEDEDPAARRRKKKSYYAKLRQQEIERERELAEKYRDRAKERRDGVNKDYEETELISTTANYRAVGPTAEADKSAAEKRRQLIQESKFLGGDMEHTHLVKGLDFALLQKVRAEIASKEKEEEELMEKPQKETKKDEDPENKIEFKTRLGRNVYRMLFKSKAYERNELFLPGRMAYVVDLDDEYADTDIPTTLIRSKADCPTMEAQTTLTTNDIVISKLTQILSYLRQGTRNKKLKKKDKGKLEEKKPPEADMNIFEDIGDYVPSTTKTPRDKERERYRERERDRERDRDRDRERERERDRERERERDREREEEKKRHSYFEKPKVDDEPMDVDKGPGSTKELIKSINEKFAGSAGWEGTESLKKPEDKKQLGDFFGMSNSYAECYPATMDDMAVDSDEEVDYSKMDQGNKKGPLGRWDFDTQEEYSEYMNNKEALPKAAFQYGIKMSEGRKTRRFKETNDKAELDRQWKKISAIIEKRKKMEADGVEVKRPKY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPERDSEPFSNPL --CCCCCCCCCCCCC | 54.08 | 20068231 | |
10 | Phosphorylation | ERDSEPFSNPLAPDG CCCCCCCCCCCCCCC | 48.53 | 20068231 | |
25 | Phosphorylation | HDVDDPHSFHQSKLT CCCCCCCCCHHHHCC | 29.79 | 23186163 | |
29 | Phosphorylation | DPHSFHQSKLTNEDF CCCCCHHHHCCHHHH | 22.51 | 23186163 | |
30 | Ubiquitination | PHSFHQSKLTNEDFR CCCCHHHHCCHHHHH | 53.40 | - | |
38 | Sumoylation | LTNEDFRKLLMTPRA CCHHHHHHHHCCCCC | 46.06 | - | |
38 | Sumoylation | LTNEDFRKLLMTPRA CCHHHHHHHHCCCCC | 46.06 | - | |
38 | Ubiquitination | LTNEDFRKLLMTPRA CCHHHHHHHHCCCCC | 46.06 | - | |
42 | Phosphorylation | DFRKLLMTPRAAPTS HHHHHHCCCCCCCCC | 15.02 | 21712546 | |
48 | Phosphorylation | MTPRAAPTSAPPSKS CCCCCCCCCCCCCCC | 32.56 | 20068231 | |
49 | Phosphorylation | TPRAAPTSAPPSKSR CCCCCCCCCCCCCCC | 37.41 | 25159151 | |
53 | Phosphorylation | APTSAPPSKSRHHEM CCCCCCCCCCCCCCC | 42.05 | 28634298 | |
54 | Acetylation | PTSAPPSKSRHHEMP CCCCCCCCCCCCCCC | 58.23 | 24886839 | |
54 | Ubiquitination | PTSAPPSKSRHHEMP CCCCCCCCCCCCCCC | 58.23 | - | |
55 | Phosphorylation | TSAPPSKSRHHEMPR CCCCCCCCCCCCCCC | 40.98 | 28634298 | |
83 | Acetylation | KKKSYYAKLRQQEIE HHHHHHHHHHHHHHH | 28.25 | 19608861 | |
83 | Ubiquitination | KKKSYYAKLRQQEIE HHHHHHHHHHHHHHH | 28.25 | 19608861 | |
98 | Acetylation | RERELAEKYRDRAKE HHHHHHHHHHHHHHH | 39.72 | 19608861 | |
98 | Ubiquitination | RERELAEKYRDRAKE HHHHHHHHHHHHHHH | 39.72 | 19608861 | |
112 | Ubiquitination | ERRDGVNKDYEETEL HHHCCCCCCHHHHHH | 60.32 | - | |
114 | Phosphorylation | RDGVNKDYEETELIS HCCCCCCHHHHHHHE | 19.78 | 28796482 | |
117 | Phosphorylation | VNKDYEETELISTTA CCCCHHHHHHHEEEC | 24.93 | 28796482 | |
121 | Phosphorylation | YEETELISTTANYRA HHHHHHHEEECCCEE | 32.12 | 28060719 | |
122 | Phosphorylation | EETELISTTANYRAV HHHHHHEEECCCEEC | 23.96 | 28060719 | |
123 | Phosphorylation | ETELISTTANYRAVG HHHHHEEECCCEECC | 13.20 | 28060719 | |
126 | Phosphorylation | LISTTANYRAVGPTA HHEEECCCEECCCCH | 9.48 | 28796482 | |
137 | Acetylation | GPTAEADKSAAEKRR CCCHHHCHHHHHHHH | 49.38 | 23749302 | |
138 | Phosphorylation | PTAEADKSAAEKRRQ CCHHHCHHHHHHHHH | 33.00 | 21712546 | |
142 | Ubiquitination | ADKSAAEKRRQLIQE HCHHHHHHHHHHHHH | 48.42 | - | |
151 | Sumoylation | RQLIQESKFLGGDME HHHHHHHHCCCCCCC | 43.80 | - | |
151 | Sumoylation | RQLIQESKFLGGDME HHHHHHHHCCCCCCC | 43.80 | 28112733 | |
151 | Ubiquitination | RQLIQESKFLGGDME HHHHHHHHCCCCCCC | 43.80 | - | |
164 | Ubiquitination | MEHTHLVKGLDFALL CCHHHHHCCHHHHHH | 61.18 | - | |
173 | Sumoylation | LDFALLQKVRAEIAS HHHHHHHHHHHHHHC | 33.39 | - | |
173 | 2-Hydroxyisobutyrylation | LDFALLQKVRAEIAS HHHHHHHHHHHHHHC | 33.39 | - | |
173 | Sumoylation | LDFALLQKVRAEIAS HHHHHHHHHHHHHHC | 33.39 | - | |
173 | Ubiquitination | LDFALLQKVRAEIAS HHHHHHHHHHHHHHC | 33.39 | 21890473 | |
173 | Ubiquitination | LDFALLQKVRAEIAS HHHHHHHHHHHHHHC | 33.39 | 21890473 | |
191 | Acetylation | EEEELMEKPQKETKK HHHHHHHHCCHHCCC | 38.49 | 26051181 | |
191 | Ubiquitination | EEEELMEKPQKETKK HHHHHHHHCCHHCCC | 38.49 | 2190698 | |
198 | Ubiquitination | KPQKETKKDEDPENK HCCHHCCCCCCCCHH | 74.00 | - | |
205 | Sumoylation | KDEDPENKIEFKTRL CCCCCCHHHHHHHHH | 41.78 | - | |
205 | Sumoylation | KDEDPENKIEFKTRL CCCCCCHHHHHHHHH | 41.78 | - | |
205 | Ubiquitination | KDEDPENKIEFKTRL CCCCCCHHHHHHHHH | 41.78 | - | |
209 | Ubiquitination | PENKIEFKTRLGRNV CCHHHHHHHHHCHHH | 21.68 | - | |
224 | Sumoylation | YRMLFKSKAYERNEL HHHHHCCCCHHCCCC | 56.42 | - | |
224 | Sumoylation | YRMLFKSKAYERNEL HHHHHCCCCHHCCCC | 56.42 | - | |
247 | Phosphorylation | VVDLDDEYADTDIPT EEECCHHHCCCCCCH | 19.44 | 27642862 | |
260 | Acetylation | PTTLIRSKADCPTME CHHHHHCCCCCCCCC | 38.09 | 26051181 | |
260 | Ubiquitination | PTTLIRSKADCPTME CHHHHHCCCCCCCCC | 38.09 | - | |
270 | Phosphorylation | CPTMEAQTTLTTNDI CCCCCCCCCCCCHHH | 30.71 | 28387310 | |
271 | Phosphorylation | PTMEAQTTLTTNDIV CCCCCCCCCCCHHHH | 15.27 | 28387310 | |
280 | Phosphorylation | TTNDIVISKLTQILS CCHHHHHHHHHHHHH | 15.66 | 28387310 | |
283 | Phosphorylation | DIVISKLTQILSYLR HHHHHHHHHHHHHHH | 19.80 | 23186163 | |
287 | Phosphorylation | SKLTQILSYLRQGTR HHHHHHHHHHHHCCC | 24.61 | 20873877 | |
288 | Phosphorylation | KLTQILSYLRQGTRN HHHHHHHHHHHCCCC | 11.49 | 23186163 | |
303 | Acetylation | KKLKKKDKGKLEEKK HHCCCCCCCCCCCCC | 67.82 | 7964201 | |
305 | Acetylation | LKKKDKGKLEEKKPP CCCCCCCCCCCCCCC | 59.47 | 7964211 | |
310 | Sumoylation | KGKLEEKKPPEADMN CCCCCCCCCCHHHCC | 69.91 | - | |
310 | Sumoylation | KGKLEEKKPPEADMN CCCCCCCCCCHHHCC | 69.91 | 28112733 | |
310 | Ubiquitination | KGKLEEKKPPEADMN CCCCCCCCCCHHHCC | 69.91 | - | |
325 | Phosphorylation | IFEDIGDYVPSTTKT HHHHHHHCCCCCCCC | 14.73 | 18669648 | |
328 | Phosphorylation | DIGDYVPSTTKTPRD HHHHCCCCCCCCCCH | 38.37 | 25159151 | |
329 | Phosphorylation | IGDYVPSTTKTPRDK HHHCCCCCCCCCCHH | 26.66 | 29978859 | |
330 | Phosphorylation | GDYVPSTTKTPRDKE HHCCCCCCCCCCHHH | 36.94 | 25159151 | |
331 | Sumoylation | DYVPSTTKTPRDKER HCCCCCCCCCCHHHH | 57.53 | 28112733 | |
331 | Ubiquitination | DYVPSTTKTPRDKER HCCCCCCCCCCHHHH | 57.53 | - | |
332 | Phosphorylation | YVPSTTKTPRDKERE CCCCCCCCCCHHHHH | 22.82 | 21712546 | |
382 | Phosphorylation | EEEKKRHSYFEKPKV HHHHHHHHCCCCCCC | 35.23 | 27251275 | |
383 | Phosphorylation | EEKKRHSYFEKPKVD HHHHHHHCCCCCCCC | 15.05 | - | |
386 | Acetylation | KRHSYFEKPKVDDEP HHHHCCCCCCCCCCC | 39.99 | 19608861 | |
386 | Sumoylation | KRHSYFEKPKVDDEP HHHHCCCCCCCCCCC | 39.99 | 28112733 | |
388 | Sumoylation | HSYFEKPKVDDEPMD HHCCCCCCCCCCCCC | 70.17 | - | |
388 | Sumoylation | HSYFEKPKVDDEPMD HHCCCCCCCCCCCCC | 70.17 | 28112733 | |
394 | Sulfoxidation | PKVDDEPMDVDKGPG CCCCCCCCCCCCCCC | 8.04 | 21406390 | |
398 | Acetylation | DEPMDVDKGPGSTKE CCCCCCCCCCCCHHH | 67.84 | 26051181 | |
402 | Phosphorylation | DVDKGPGSTKELIKS CCCCCCCCHHHHHHH | 39.17 | 30576142 | |
403 | Phosphorylation | VDKGPGSTKELIKSI CCCCCCCHHHHHHHH | 34.16 | 30576142 | |
404 | Sumoylation | DKGPGSTKELIKSIN CCCCCCHHHHHHHHH | 52.82 | - | |
404 | Sumoylation | DKGPGSTKELIKSIN CCCCCCHHHHHHHHH | 52.82 | 28112733 | |
404 | Ubiquitination | DKGPGSTKELIKSIN CCCCCCHHHHHHHHH | 52.82 | - | |
408 | Sumoylation | GSTKELIKSINEKFA CCHHHHHHHHHHHHC | 58.89 | - | |
408 | Acetylation | GSTKELIKSINEKFA CCHHHHHHHHHHHHC | 58.89 | 19608861 | |
408 | Sumoylation | GSTKELIKSINEKFA CCHHHHHHHHHHHHC | 58.89 | 28112733 | |
408 | Ubiquitination | GSTKELIKSINEKFA CCHHHHHHHHHHHHC | 58.89 | 19608861 | |
409 | Phosphorylation | STKELIKSINEKFAG CHHHHHHHHHHHHCC | 24.53 | 30108239 | |
413 | Sumoylation | LIKSINEKFAGSAGW HHHHHHHHHCCCCCC | 35.71 | - | |
413 | Sumoylation | LIKSINEKFAGSAGW HHHHHHHHHCCCCCC | 35.71 | - | |
413 | Ubiquitination | LIKSINEKFAGSAGW HHHHHHHHHCCCCCC | 35.71 | - | |
417 | Phosphorylation | INEKFAGSAGWEGTE HHHHHCCCCCCCCHH | 21.85 | 30108239 | |
423 | Phosphorylation | GSAGWEGTESLKKPE CCCCCCCHHHCCCHH | 15.75 | 20068231 | |
425 | Phosphorylation | AGWEGTESLKKPEDK CCCCCHHHCCCHHHH | 45.38 | 23186163 | |
442 | Phosphorylation | LGDFFGMSNSYAECY HHHHHCCCCCHHHHE | 24.01 | 27251275 | |
444 | Phosphorylation | DFFGMSNSYAECYPA HHHCCCCCHHHHEEC | 20.57 | 27251275 | |
445 | Phosphorylation | FFGMSNSYAECYPAT HHCCCCCHHHHEECC | 15.63 | 26657352 | |
449 | Phosphorylation | SNSYAECYPATMDDM CCCHHHHEECCHHHC | 6.34 | 26657352 | |
452 | Phosphorylation | YAECYPATMDDMAVD HHHHEECCHHHCCCC | 19.34 | 18669648 | |
460 | Phosphorylation | MDDMAVDSDEEVDYS HHHCCCCCCCCCCHH | 40.08 | 20058876 | |
466 | Phosphorylation | DSDEEVDYSKMDQGN CCCCCCCHHHCCCCC | 18.50 | 26074081 | |
467 | Phosphorylation | SDEEVDYSKMDQGNK CCCCCCHHHCCCCCC | 19.62 | 23090842 | |
485 | Phosphorylation | LGRWDFDTQEEYSEY CCCCCCCCHHHHHHH | 37.56 | 17525332 | |
489 | Phosphorylation | DFDTQEEYSEYMNNK CCCCHHHHHHHHCCC | 13.17 | 28796482 | |
490 | Phosphorylation | FDTQEEYSEYMNNKE CCCHHHHHHHHCCCC | 26.07 | 28796482 | |
492 | Phosphorylation | TQEEYSEYMNNKEAL CHHHHHHHHCCCCHH | 10.13 | 28796482 | |
496 | Sumoylation | YSEYMNNKEALPKAA HHHHHCCCCHHCHHH | 39.08 | 28112733 | |
501 | Sumoylation | NNKEALPKAAFQYGI CCCCHHCHHHHHHCC | 53.87 | - | |
501 | Sumoylation | NNKEALPKAAFQYGI CCCCHHCHHHHHHCC | 53.87 | 28112733 | |
501 | Ubiquitination | NNKEALPKAAFQYGI CCCCHHCHHHHHHCC | 53.87 | - | |
506 | Phosphorylation | LPKAAFQYGIKMSEG HCHHHHHHCCCCCCC | 17.86 | 28152594 | |
509 | Sumoylation | AAFQYGIKMSEGRKT HHHHHCCCCCCCCCC | 31.82 | 28112733 | |
509 | Ubiquitination | AAFQYGIKMSEGRKT HHHHHCCCCCCCCCC | 31.82 | - | |
516 | Phosphorylation | KMSEGRKTRRFKETN CCCCCCCCCCCHHCC | 26.22 | 22798277 | |
520 | Methylation | GRKTRRFKETNDKAE CCCCCCCHHCCCHHH | 62.91 | 115971385 | |
520 | Ubiquitination | GRKTRRFKETNDKAE CCCCCCCHHCCCHHH | 62.91 | - | |
522 | Phosphorylation | KTRRFKETNDKAELD CCCCCHHCCCHHHHH | 49.67 | 23532336 | |
530 | Methylation | NDKAELDRQWKKISA CCHHHHHHHHHHHHH | 57.81 | 115480229 | |
534 | Ubiquitination | ELDRQWKKISAIIEK HHHHHHHHHHHHHHH | 38.65 | - | |
536 | Phosphorylation | DRQWKKISAIIEKRK HHHHHHHHHHHHHHH | 23.46 | 28112733 | |
541 | 2-Hydroxyisobutyrylation | KISAIIEKRKKMEAD HHHHHHHHHHHCCCC | 60.14 | - | |
541 | Acetylation | KISAIIEKRKKMEAD HHHHHHHHHHHCCCC | 60.14 | 25953088 | |
541 | Sumoylation | KISAIIEKRKKMEAD HHHHHHHHHHHCCCC | 60.14 | 28112733 | |
541 | Ubiquitination | KISAIIEKRKKMEAD HHHHHHHHHHHCCCC | 60.14 | - | |
543 | Sumoylation | SAIIEKRKKMEADGV HHHHHHHHHCCCCCC | 68.49 | 28112733 | |
544 | Sumoylation | AIIEKRKKMEADGVE HHHHHHHHCCCCCCE | 46.11 | - | |
544 | Sumoylation | AIIEKRKKMEADGVE HHHHHHHHCCCCCCE | 46.11 | 28112733 | |
553 | Sumoylation | EADGVEVKRPKY--- CCCCCEECCCCC--- | 49.86 | - | |
553 | Acetylation | EADGVEVKRPKY--- CCCCCEECCCCC--- | 49.86 | 25953088 | |
553 | Sumoylation | EADGVEVKRPKY--- CCCCCEECCCCC--- | 49.86 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RED_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RED_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RED_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83; LYS-98; LYS-386 ANDLYS-408, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-485, AND MASSSPECTROMETRY. |